Lamivudine And Zidovudine 33342-0003-09
- Manufacturer
- Macleods Pharmaceuticals Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 30, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA090679
Need to source Lamivudine And Zidovudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 150 mg/1 |
| Zidovudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Selected Package
33342-0003-09Selected60 TABLET in 1 BOTTLE (33342-003-09)